Dawn Halkuff serves as Executive at Xeris Biopharma Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Dawn Halkuff has executed 5 insider transactions totaling $319.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 12, 2025 involved selling 42,500 shares valued at $309.4K.
Dawn Halkuff currently holds 115,000 shares of Xeris Biopharma Holdings, Inc. (XERS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dawn Halkuff has been a net seller of XERS stock. They have purchased $10.0K and sold $309.4K worth of shares.
Dawn Halkuff's most recent insider trade was on Aug 12, 2025, when they sold 42,500 shares at $7.28 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 20, 2023 | XERS | $10.0K | Purchase | 5,410 | $1.84 | Discretionary |
| Jun 7, 2023 | XERS | $0 | Award | 42,500 | $N/A | Discretionary |
| Jun 8, 2022 | XERS | $0 | Award | 15,000 | $N/A | Discretionary |